Yahoo · Feb 25, 2026
Totaligent Executes Binding LOI for Joint Venture and Acquisition of GloMed Solutions
Strategic Partnership to Integrate Aetherium Medical Platform with Japanese Medical Aesthetics and Biologics Distributor to Drive Rapid Expansion in APAC MarketsBOCA RATON, Fla., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Totaligent, Inc. (OTCID: TGNT)(“Totaligent” or “the Company”), an emerging leader in intelligent business marketing data solutions, today announced the execution of a binding Letter of Intent (LOI) with GloMed Solutions Limited Liability Company ("GloMed"), a Japanese medical aesthetics

